| Group | No | Immunization | Challenge | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Age (d) | Virus | Virus titer (TCID50/dose) | Route | Age (d) | Virus | Virus titer (TCID50/dose) | Route | ||
| A | 9 | 1 | FAdV-4 | 4.54 × 106 | PO | 14 | YS4 | 6.31 × 108 | IM |
| B | 9 | 1 | FAdV-4 | 4.54 × 106 | PO | 14 | – | – | – |
| C | 9 | 1 | – | – | – | 14 | YS4 | 6.31 × 108 | IM |
| D | 9 | 1 | – | – | – | 14 | – | – | – |